177 related articles for article (PubMed ID: 34269398)
1. Diagnosis and management of combined post- and precapillary pulmonary hypertension in a patient with multiple comorbidities.
Panagiotidou E; Boutou A; Kalamara E; Sourla E; Chatzopoulos E; Stanopoulos I; Pitsiou G
Adv Respir Med; 2021; 89(4):444-447. PubMed ID: 34269398
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary hypertension in chronic respiratory diseases].
Cottin V
Presse Med; 2014 Sep; 43(9):945-56. PubMed ID: 25123317
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary hypertension in interstitial lung diseases: diagnostic and therapeutic approach in 2011?].
Cottin V; Kiakouama L; Traclet J; Cordier JF
Presse Med; 2011 Apr; 40 Suppl 1():1S39-45. PubMed ID: 21536179
[TBL] [Abstract][Full Text] [Related]
5. [2022 ESC/ERS guidelines on the diagnostics and treatment of pulmonary hypertension : A focussed review].
Rosenkranz S
Herz; 2023 Feb; 48(1):23-30. PubMed ID: 36648489
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary arterial hypertension.
Montani D; Günther S; Dorfmüller P; Perros F; Girerd B; Garcia G; Jaïs X; Savale L; Artaud-Macari E; Price LC; Humbert M; Simonneau G; Sitbon O
Orphanet J Rare Dis; 2013 Jul; 8():97. PubMed ID: 23829793
[TBL] [Abstract][Full Text] [Related]
7. Effects of ambrisentan in a patient affected by combined pulmonary fibrosis and emphysema and by severe pulmonary hypertension: clinical, functional, and biomolecular findings.
Roccia F; Campolo B; Gallelli L; Spaccarotella C; Mongiardo A; Falcone D; Savino R; Pelaia G; Indolfi C; Maselli R
Clin Drug Investig; 2013 Jun; 33(6):451-7. PubMed ID: 23605508
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects].
Palazzini M; Manes A; Negro L; Marinelli A; Leci E; Gambetti S; Bachetti C; Beciani E; Conficoni E; Branzi A; Galiè N
G Ital Cardiol (Rome); 2009 May; 10(5):271-300. PubMed ID: 19537440
[TBL] [Abstract][Full Text] [Related]
9. [Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 1)].
Chazova IE; Martynyuk TV
Ter Arkh; 2016; 88(9):90-101. PubMed ID: 27735920
[TBL] [Abstract][Full Text] [Related]
10. [Problematic aspects of pulmonary hypertension due to left heart disease: focus on combined postcapillary and precapillary pulmonary hypertension].
Aleevskaya AM; Vyborov ON; Gramovich VV; Martynyuk TV
Ter Arkh; 2020 Oct; 92(9):54-62. PubMed ID: 33346432
[TBL] [Abstract][Full Text] [Related]
11. Chronic Thromboembolic Pulmonary Hypertension: Experience from a Single Center in Mexico.
Al-Naamani N; Espitia H G; Velazquez-Moreno H; Macuil-Chazaro B; Serrano-Lopez A; Vega-Barrientos RS; Hill NS; Preston IR
Lung; 2016 Apr; 194(2):315-23. PubMed ID: 26748498
[TBL] [Abstract][Full Text] [Related]
12. Echocardiographic and Hemodynamic Predictors of Survival in Precapillary Pulmonary Hypertension: Seven-Year Follow-Up.
Grapsa J; Pereira Nunes MC; Tan TC; Cabrita IZ; Coulter T; Smith BC; Dawson D; Gibbs JS; Nihoyannopoulos P
Circ Cardiovasc Imaging; 2015 Jun; 8(6):. PubMed ID: 26063743
[TBL] [Abstract][Full Text] [Related]
13. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry.
Frost AE; Farber HW; Barst RJ; Miller DP; Elliott CG; McGoon MD
Chest; 2013 Jan; 143(1):185-195. PubMed ID: 22661451
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases].
Nikolaeva EV; Yudkina NN; Kurmukov IA; Novikova DS; Markelova EI; Volkov AV
Ter Arkh; 2015; 87(5):24-32. PubMed ID: 26155616
[TBL] [Abstract][Full Text] [Related]
15. Group 3 Pulmonary Hypertension: A Review of Diagnostics and Clinical Trials.
Shioleno AM; Ruopp NF
Clin Chest Med; 2021 Mar; 42(1):59-70. PubMed ID: 33541617
[TBL] [Abstract][Full Text] [Related]
16. Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension.
Olsson KM; Frank A; Fuge J; Welte T; Hoeper MM; Bitter T
Respir Res; 2015 Nov; 16():137. PubMed ID: 26538143
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.
Naeije R; Gerges M; Vachiery JL; Caravita S; Gerges C; Lang IM
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912263
[TBL] [Abstract][Full Text] [Related]
18. Definitions and diagnosis of pulmonary hypertension.
Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management.
Lee F; Mielniczuk LM
Can J Cardiol; 2021 Apr; 37(4):572-584. PubMed ID: 33217522
[TBL] [Abstract][Full Text] [Related]
20. Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management.
Cottin V
BMC Res Notes; 2013; 6 Suppl 1(Suppl 1):S2. PubMed ID: 23734851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
